Valeant Pharmaceuticals Inc Chief Executive Officer Mike Pearson said on Tuesday that he sees no need to adjust the company's offer for Allergan Inc . Valeant's bid includes both stock and cash, but its shares have fallen for 10 straight sessions.
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN traded higher by 0.08% or $0.13/share to $159.50. In the past year, the shares have traded as low as $81.33 and as high as $172.48. On average, 4670100 shares of AGN exchange hands on a given day and today's volume is recorded at 307122.
Source
